On the other hand, in resected pancreatic cancer patients, CCL2 is an independent favorable prognostic factor with indirect effects on pancreatic cancer cell growth via cytokines, such as IL1B [35]. This evidence concerns the gene CCL2 and familial pancreatic carcinoma.